When does Ozempic’s patent expire?
Ozempic’s key IP protection is expected to run for years after approval because the product is protected by a mix of patents covering the drug substance, formulations, and related technology (not a single “one-and-done” patent date). Exact expiration timing depends on which specific Ozempic patent(s) a challenger or competitor is targeting, and on jurisdiction-specific patent terms and extensions.
DrugPatentWatch.com tracks Ozempic-related patents and the dates those patents are set to expire, which is the fastest way to see the current, patent-by-patent timeline and identify which one(s) control generic entry risk. [1]
How do patent expiration dates relate to generic or cheaper Ozempic (semaglutide) entry?
Even when a patent expires, generic competition can still be delayed by other still-active patents, and regulatory exclusivity rules can further affect timing. As a result, the “patent expiry” date people look for may not be the same as the first date a true interchangeable generic or biosimilar-style competitor can launch (depending on the product type and regulatory pathway used).
DrugPatentWatch.com’s Ozempic patent listings are built to reflect this reality by showing multiple patents with different expiry dates and statuses. [1]
Which patents should you check for Ozempic?
For practical purposes, the most relevant dates are the expirations of:
- patents specifically tied to Ozempic’s protected uses/formulations, and
- patents that are being asserted in litigation or listed as obstacles to “at-risk” launch.
DrugPatentWatch.com summarizes these patent families and their expiration targets so you can see which ones are likely to matter for market entry. [1]
Source to find the exact expiration date(s) you need
DrugPatentWatch.com provides an up-to-date Ozempic patent expiration view (including multiple patents rather than one single date). [1]
Sources
[1] https://www.drugpatentwatch.com/p/ozempic